Martingale Asset Management L P Increases Position in CorVel Co. (NASDAQ:CRVL)

Martingale Asset Management L P lifted its position in shares of CorVel Co. (NASDAQ:CRVL) by 192.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 26,115 shares of the business services provider’s stock after purchasing an additional 17,170 shares during the period. Martingale Asset Management L P owned about 0.05% of CorVel worth $2,906,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Fifth Third Bancorp boosted its position in shares of CorVel by 45.9% during the 4th quarter. Fifth Third Bancorp now owns 321 shares of the business services provider’s stock worth $36,000 after acquiring an additional 101 shares in the last quarter. Jones Financial Companies Lllp acquired a new position in CorVel in the fourth quarter valued at approximately $37,000. US Bancorp DE increased its stake in CorVel by 225.4% in the fourth quarter. US Bancorp DE now owns 384 shares of the business services provider’s stock valued at $43,000 after purchasing an additional 266 shares during the last quarter. GAMMA Investing LLC raised its holdings in CorVel by 175.2% during the fourth quarter. GAMMA Investing LLC now owns 432 shares of the business services provider’s stock worth $48,000 after purchasing an additional 275 shares in the last quarter. Finally, CIBC Private Wealth Group LLC lifted its position in shares of CorVel by 300.0% during the 4th quarter. CIBC Private Wealth Group LLC now owns 480 shares of the business services provider’s stock worth $53,000 after buying an additional 360 shares during the last quarter. Institutional investors and hedge funds own 51.36% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, StockNews.com raised shares of CorVel from a “hold” rating to a “buy” rating in a research report on Tuesday.

Insider Buying and Selling at CorVel

In other news, Director Alan Hoops sold 10,200 shares of CorVel stock in a transaction dated Tuesday, February 18th. The shares were sold at an average price of $116.39, for a total value of $1,187,178.00. Following the sale, the director now owns 118,213 shares of the company’s stock, valued at $13,758,811.07. The trade was a 7.94 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Jeffrey J. Michael sold 16,523 shares of the stock in a transaction dated Wednesday, April 9th. The stock was sold at an average price of $116.99, for a total transaction of $1,933,025.77. Following the transaction, the director now directly owns 551,787 shares of the company’s stock, valued at $64,553,561.13. This represents a 2.91 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 48,723 shares of company stock valued at $5,757,140 in the last ninety days. Insiders own 47.57% of the company’s stock.

CorVel Stock Down 0.6 %

NASDAQ:CRVL opened at $114.90 on Friday. The company has a market capitalization of $5.90 billion, a PE ratio of 67.59 and a beta of 0.94. CorVel Co. has a 52-week low of $76.20 and a 52-week high of $128.61. The stock’s 50 day moving average price is $111.78 and its 200 day moving average price is $114.98.

CorVel (NASDAQ:CRVL) last announced its earnings results on Tuesday, February 4th. The business services provider reported $0.46 EPS for the quarter. CorVel had a net margin of 10.12% and a return on equity of 32.22%.

CorVel Company Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.